logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5667.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5667.produseast1
Showing 1 - 13 of 13 Items
Showing 1 - 13 of 13 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Pre-Print

Effect of smoking on drug-resistant tuberculosis treatment outcomes and exploring potential pathways: A multicountry cohort study

Romo ML, LaHood A, Stagg HR, Mitnick CD, Trevisi L,  et al.
2025-08-24 • medRxiv
2025-08-24 • medRxiv

People who smoke are at increased risk of unfavorable tuberculosis (TB) treatment outcomes compared with tho...

Journal Article
|
Research
Journal Article
|
Pre-Print
Journal Article
|
Research
Journal Article
|
Research
Journal Article
|
Pre-Print
Journal Article
|
Research
Journal Article
|
Pre-Print
Journal Article
|
Pre-Print
Journal Article
|
Pre-Print
Journal Article
|
Research
Journal Article
|
Pre-Print
Journal Article
|
Pre-Print

Risk stratification of childhood infection using host markers of immune and endothelial activation: A multi-country prospective cohort study in Asia (Spot Sepsis)

Chandna A, Koshiaris C, Mahajan R, Ahmad RA, Anh DTV,  et al.
2025-02-05 • medRxiv
2025-02-05 • medRxiv

BACKGROUND

Circulating markers of immune and endothelial activation risk stratify infection syndromes agnostic to disease aetiology. However, their utility in c...

HLA-A*03:01 is associated with visceral leishmaniasis development in people living with HIV in Ethiopia

de Vrij N, Vandoren R, Ramadan K, Van Hul A, Kassa M,  et al.
2024-02-18 • medRxiv
2024-02-18 • medRxiv
Human immunodeficiency virus (HIV) co-infection is a major challenge for visceral leishmaniasis (VL) control, particularly in Ethiopia where the incidence of both pathogens is high. VL-H...

Nine-month, all-oral regimens for rifampin-resistant tuberculosis

Guglielmetti L, Khan U, Velasquez GE, Gouillou M, Abubakirov A,  et al.
2024-01-29 • medRxiv
2024-01-29 • medRxiv

BACKGROUND

Aft...

Effectiveness of a bedaquiline, linezolid, clofazimine “core” for multidrug-resistant tuberculosis

Zeng C, Hernán MA, Trevisi L, Sauer S, Mitnick CD,  et al.
2024-01-20 • medRxiv
2024-01-20 • medRxiv

RATIONALE

Treatment outcomes may be compromised among patients with multidrug- or rifampicin-resistant tuberculosis with additional fluoroquinolone resis...

Factors associated with adverse outcomes among patients hospitalized at a COVID-19 treatment center run by Médecins sans Frontières in Herat, Afghanistan

Klein A, Bastard M, Hemat H, Singh SN, Muniz B,  et al.
2023-02-16 • medRxiv
2023-02-16 • medRxiv
BACKGROUND
Though many studies on COVID have been published to date, data on COVID-19 epidemiology, symptoms, risk factors and severity in low- and middle-income countries (LMICS), s...

The impact of reactive mass vaccination campaigns on measles outbreaks in the Katanga region, Democratic Republic of Congo

Funk S, Takahashi S, Hellewell J, Gadroen K, Carrion Martin AI,  et al.
2019-08-17 • medRxiv
2019-08-17 • medRxiv
The Katanga region in the Democratic Republic of Congo (DRC) has been struck by repeated epidemics of measles, with large outbreaks occurring in 2010–13 and 2015. In many of the affected...

The validity and reliability of parent’s recall for routine immunization in Cameroon: an evaluative study

Yakum MN, Funwie AD, Tsafack M, Ebaze LE, Ajong AB,  et al.
2022-02-21 • medRxiv
2022-02-21 • medRxiv
OBJECTIVE
The objective of this study was to determine the validity of parent’s recall for immunization using the vaccination card as the reference in Yaounde-Cameroon.

SETT...

The burden of vaccine hesitancy for routine immunization in Yaounde-Cameroon: restrictive sampling technique

Yakum MN, Funwie AD, Ajong AB, Tsafack M, Ebaze LE,  et al.
2022-02-21 • medRxiv
2022-02-21 • medRxiv
Immunization is the most cost-effective health intervention in the world yet, vaccination uptake is still low with less than 50% of children aged 12-23 months fully vaccinated Cameroon. ...

Clinical profile and factors associated with COVID-19 in Cameroon: a prospective cohort study

Fouda Mbarga N, Emilienne E, Mbarga M, Ouamba P, Nanda H,  et al.
2021-02-23 • medRxiv
2021-02-23 • medRxiv
OBJECTIVES
This study explores the clinical profiles and factors associated with COVID-19 in Cameroon.

RESEARCH DESIGN AND METHODS
In this prospective cohort study, we f...

Description of a community paediatric strategy offering a package of services to prevent malnutrition among children in one health district in Mali

Roederer T, Llosa AE, Shepherd S, Defourny I, Lacharite M,  et al.
2021-01-26 • medRxiv
2021-01-26 • medRxiv
Background We present results from an intervention case study, the Soins Preventifs de l’Enfant (SPE) project, in Konséguéla health area, Mali. The intervention involved a network of com...

Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis

Sweeney S, Berry C, Kazounis E, Motta I, Vassall A,  et al.
2022-11-10 • medRxiv
2022-11-10 • medRxiv
INTRODUCTION
Current options for treating tuberculosis (TB) that is resistant to rifampicin (RR-TB) are few, and regimens are often long and poorly tolerated. Following recent eviden...

Effectiveness of Typhoid Conjugate Vaccine in Zimbabwe used in response to an outbreak among children and young adults: a matched case control study

Lightowler M, Manangazira P, Nackers F, Van Herp M, Phiri I,  et al.
2022-03-31 • medRxiv
2022-03-31 • medRxiv
BACKGROUND
Zimbabwe suffers from regular outbreaks of typhoid fever (TF), worse since 2017. Most cases were in Harare and a vaccination campaign with Typhoid Conjugate Vaccine (TCV) ...